IP Library Granted Patent US 9,815,694
Granted Patent B2
US 9,815,694 · App. 14/515,716 · Granted Nov 14, 2017

Catalytic ammonia synthesis by transition metal molecular complexes

Inventors: Jonas C. Peters (Pasadena, CA); John S. Anderson (Evanston, IL); Sidney E. Cruetz (Pasadena, CA); Jonathan D. Rittle (Los Angeles, CA)
Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
C01B21/16B01J31/1608B01J31/189B01J31/2409C01C1/026B01J2231/62B01J2531/0236B01J2531/0247B01J2531/842B01J2531/845B01J2540/50Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,815,694
App. No.
14/515,716
Granted
Nov 14, 2017
Kind
B2
Abstract

This invention relates to molecular catalysts and chemical reactions utilizing the same, and particularly to catalysts and catalytic methods for reduction of molecular nitrogen. The molecular catalytic platform provided herein is capable of the facile reduction of molecular nitrogen under useful conditions such as room temperature or less and atmospheric pressure or less.

Claims (52)

1. A catalytic process for reduction of molecular nitrogen (N 2 ) to generate a reduction product, said process comprising the steps of:

contacting a transition metal catalyst with a source of protons and a source of electrons in the presence of said molecular nitrogen, thereby generating said reduction product;

wherein said transition metal catalyst comprises a metal complex comprising a transition metal atom selected from the group consisting of Fe and Co, and a phosphine ligand (L) having the formula (FX1A), (FX1B) or (FX1C):

wherein:

X 1 is B, C, Si or P;

each of L 1 , L 2 and L 3 is independently a substituted or unsubstituted C 1 -C 10 alkylene, C 3 -C 10 cycloalkylene, C 5 -C 10 arylene, or C 5 -C 10 heteroarylene;

each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is independently hydrogen or a substituted or unsubstituted C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 5 -C 8 aryl, C 5 -C 8 heteroaryl, C 1 -C 18 acyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, or —P(OR 8 ) 2 , wherein each R 8 is independently hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 5 -C 8 aryl or C 5 -C 8 heteroaryl.

2. The catalytic process of claim 1 , wherein said metal complex further comprises N 2 and has the formula (FX2A), (FX2B) or (FX2C):

wherein Z is said transition metal atom.

3. The process of claim 1 , wherein said step of contacting said transition metal catalyst with said source of protons and said source of electrons in the presence of said molecular nitrogen further regenerates said transition metal catalyst.

4. The process of claim 1 , wherein said reduction product is NH 3 or N 2 H 4 .

5. The process of claim 1 , wherein said transition metal catalyst further comprises a N 2 group; wherein said transition metal catalyst has the formula: (L)Z(N 2 ) − (FX3); wherein L is said phosphine ligand and Z is said transition metal atom.

6. The process of claim 5 further comprising the step of protonating said transition metal catalyst so as to generate a hydrogenated metal-N 2 complex; wherein protonating occurs via contacting said transition metal catalyst with an acid.

7. The process of claim 6 , wherein said hydrogenated metal-N 2 complex has the formula (FX4), (FX5A) or (FX5B):

(L)Z(N x H y ) (FX4), (L)Z(NH 2 ) (FX5A) or (L)Z(NH 3 ) + (FX5B);

wherein x is 1 or 2; y is 1, 2, 3, 4 or 5; L is said phosphine ligand and Z is said transition metal atom.

8. The process of claim 6 , further comprising reductive protonation of said hydrogenated metal-N 2 complex, thereby generating said reduction product and regenerating said transition metal catalyst.

9. The process of claim 1 further comprising the step of:

providing a transition metal catalyst precursor comprising a precursor transition metal complex comprising said transition metal atom and said phosphine ligand (L); and

contacting said transition metal catalyst precursor with molecular nitrogen in the presence of an acid and a reductant, thereby generating said transition metal catalyst comprising a N 2 adduct of said transition metal catalyst precursor;

wherein said transition metal catalyst precursor has the formula:

(L)Z + (FX6);

wherein L is said phosphine ligand and Z is said transition metal atom.

10. The process of claim 9 , wherein said transition metal catalyst is generated via reduction of said transition metal catalyst precursor wherein said reducing agent is Na, Na/Hg or KC 8 .

11. The process of claim 1 , wherein said transition metal catalyst is a mononuclear metal complex, wherein said transition metal atom is Fe and characterized by an oxidation state of Fe(−1), Fe(0), Fe(I), Fe(II), Fe(III), or Fe(IV).

12. The process of claim 1 , wherein said phosphine ligand is a tripodal trisphosphine ligand having a boron, carbon, silicon or phosphorous axial donor atom.

13. The process of claim 1 , wherein said phosphine ligand has an aryl backbone comprising at least one of L 1 , L 2 and L 3 independently comprising C 5 -C 10 arylene or C 5 -C 10 heteroarylene or wherein said phosphine ligand comprises one or more cyclohexylamine ring systems.

14. The process of claim 1 , wherein said ligand of said transition metal catalyst has the formula (FX7A), (FX7B) or (FX7C):

15. The process of claim 14 , wherein said metal complex further comprises N 2 and has the formula (FX8A), (FX8B) or (FX8C):

wherein Z is said transition metal atom.

16. The process of claim 1 , wherein said ligand of said transition metal catalyst has the formula (FX9A), (FX9B) or (FX9C):

17. The process of claim 1 , wherein said ligand of said transition metal catalyst has formula (FX10A), (FX10B) or (FX10C):

wherein i Pr is isopropyl, Ph is phenyl and Cy is cyclohexyl.

18. The process of claim 1 , wherein said ligand of said transition metal catalyst has formula (FX10A), (FX10B), (FX10C) or (FX10D):

wherein iPr is isopropyl, Ph is phenyl and Cy is cyclohexyl.

19. The process of claim 1 , wherein said transition metal catalyst has the formula [(TP R B)Fe(N 2 )] − , [(CP R 3 )Fe(N 2 )] − , [(SiP R 3 )Fe(N 2 )] − , [(TP R B)Co(N 2 )] − , [(CP R 3 )Co(N 2 )] − , or [(SiP R 3 )Co(N 2 )] − , wherein TP R B is a tris(phosphinoaryl)borane ligand, CP R 3 is a tris(phosphinoaryl)alkyl ligand and SiP R 3 is tris(phosphinoaryl)silyl ligand.

20. The process of claim 1 , wherein at least one of said molecular nitrogen said transition metal catalyst, said source of protons and said source of electrons are provided in a solution comprising one or more solvents, wherein the concentration of said molecular nitrogen in said solution is selected from the range of 1×10 −4 M to 1 M wherein the concentration of said transition metal catalyst in said solution is selected from the range of 0.01 mM to 10 mM.

21. The process of claim 1 , wherein said source of protons is one or more acids selected from the group consisting of: HBAr F 4 (hydro tetrakis[(3,5-trifluoromethyl)phenyl]borate), HOTf (triflic acid), HX, HBF 4 , ArNH 3 +X and a combination of these; wherein X is a halogen.

22. The process of claim 21 , wherein the concentration of said one or more acids is selected from the range of 0.01-5 M.

23. The process of claim 1 , wherein said source of electrons is one or more reductants selected from the group consisting of Na, K/Hg, KC 8 , Na/Hg, NaBH 4 − , Mg, Zn and any combination of these.

24. The process of claim 23 , wherein the concentration of said one or more reductants is selected from the range of 0.1-100 M.

25. The process of claim 20 , wherein said transition metal catalyst is a homogeneous catalyst, wherein said transition metal catalyst, said source of protons, said source of electrons and said molecular nitrogen are provided in contact with each other in said solution.

26. The process of claim 20 , wherein said transition metal catalyst is a heterogeneous catalyst, where said transition metal, said source of protons and said source of electrons and said molecular nitrogen are provided in said solution and provided in contact with said transition metal catalyst provided in the solid phase.

27. A catalyst formulation for reduction of molecular nitrogen (N 2 ) to generate a reduction product, said formulation comprising:

a transition metal catalyst comprising a metal complex comprising a transition metal atom selected from the group consisting of Fe and Co, and a phosphine ligand (L);

a source of protons comprising one or more acids; and

a source of electrons comprising one or more reductants; and

a phosphine ligand (L) having the formula (FX1A), (FX1B) or (FX1C):

wherein:

X 1 is B, C, Si or P;

each of L 1 , L 2 and L 3 is independently a substituted or unsubstituted C 1 -C 10 alkylene, C 3 -C 10 cycloalkylene, C 5 -C 10 arylene, or C 5 -C 10 heteroarylene;

each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 is independently hydrogen or a substituted or unsubstituted C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 5 -C 8 aryl, C 5 -C 8 heteroaryl, C 1 -C 18 acyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, or —P(OR 8 ) 2 , wherein each R 8 is independently hydrogen, C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 5 -C 8 aryl or C 5 -C 8 heteroaryl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: PETERS, JONAS C.; ANDERSON, JOHN S.; CRUETZ, SIDNEY E.; RITTLE, JONATHAN D.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 035534/0857 →
CONFIRMATORY LICENSE Recorded Dec 1, 2014
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034498/0520 →
Continuity (2)
Provisional Application 61891550 · Oct 16, 2013
Related Publication 20150104371A1 · Apr 16, 2015